Results 1 to 10 of about 5,263 (229)

Dextroamphetamine Treatment in Children With Hypothalamic Obesity [PDF]

Frontiers in Endocrinology, 2022
IntroductionHypothalamic obesity (HO) in children has severe health consequences. Lifestyle interventions are mostly insufficient and currently no drug treatment is approved for children with HO.
Jiska Van Schaik, Hanneke Margo Van Santen   +1 more
exaly   +11 more sources

Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series [PDF]

Obesity Facts, 2019
Background: A limited number of published case reports suggest a positive effect of dextroamphetamine, an adrenergic agonist affecting both the central nervous system (CNS) and peripheral nervous system, on physical activity and weight in patients with ...
Christian Denzer, Friederike Denzer, Belinda S. Lennerz, Heike Vollbach, Robert H. Lustig, Martin Wabitsch   +5 more
doaj   +3 more sources

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

Harm Reduction Journal, 2021
Background For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine ...
Heather Palis, Scott MacDonald, Jennifer Jun, Eugenia Oviedo-Joekes   +3 more
doaj   +3 more sources

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment

Substance Abuse Treatment, Prevention, and Policy, 2021
Background A high proportion of people receiving both oral and injectable opioid agonist treatment report concurrent use of stimulants (i.e. cocaine and or amphetamines), which has been associated with higher rates of continued illicit opioid use and ...
Heather Palis, Kirsten Marchand, Gerald “ Spike” Peachey, Jordan Westfall, Kurt Lock, Scott MacDonald, Jennifer Jun, Anna Bojanczyk-Shibata, Scott Harrison, David C. Marsh, Martin T. Schechter, Eugenia Oviedo-Joekes   +11 more
doaj   +3 more sources

40-Year-Old Male with Medial Gastrocnemius Tear after Adderall (Amphetamine/Dextroamphetamine) Use: A Case Report [PDF]

Journal of Orthopaedic Case Reports
Introduction: Gastrocnemius tears most commonly occur after a forceful eccentric contraction of the muscle. Adderall (i.e., amphetamine/dextroamphetamine), a commonly prescribed medication in the United States, has been proven to have many adverse ...
Christina M Melian, James Puleo, James Schneider   +2 more
doaj   +3 more sources

Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: a study protocol for the multicentre double blind randomised controlled trial ATLAS4Dependence [PDF]

BMJ Open
Introduction There is limited evidence on how to effectively treat individuals from marginalised populations with dependence on amphetamine and/or methamphetamine (collectively referred to hereafter as amphetamine dependence).
, Jörg Assmus, Kjell Arne Johansson, Nicholas Lintzeris, Fatemeh Chalabianloo, Anne Halmøy, Lars T Fadnes, Nadine Ezard, Brendan Clifford, John Fredrik Askjer, Olav Spigset, Torgeir Gilje Lid, Jon Mordal, Else-Marie Løberg, Christina Dahl Andersen, Jan Tore Daltveit, Aleksander H Erga, Kristin K Solli, Minna A K Hansen, Christian Ohldieck, Christer F Aas, Trond Aamo, Tine B Edvardsdal, Siv-Elin L Carlsen, Prayash Chaudhary, Marianne Cook Pierron, Gry I Dale, Silvana De Pirro, Karl Trygve Druckrey-Fiskaan, Zhanna Gaulen, Beate H Trettenes, Minna AK Hansen, Mette H Nordbotn, Line Holtan, Arild Knutsen, Kristin K Solli, Heidi F Kristiansen, Svanhild Mellingen, Maria K Olsvold, Solveig IS Reinertsen, Kristin Sannerud, Krista Siefried, Bente Sikveland, Morten Sommerbakk, Herman Steffensen, Jørn H Vold   +45 more
doaj   +3 more sources

Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use

American Journal of Ophthalmology Case Reports, 2022
Purpose: To report a case of central serous chorioretinopathy (CSC) associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use. Observations: A 34-year-old man presented for evaluation of a “cloud” in his vision for three months. He
Joseph B. Alsberge, Daniel Y. Lee, J. Michael Jumper   +2 more
doaj   +2 more sources

Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study

Journal of Child and Adolescent Psychopharmacology, 2022
Objectives: To assess efficacy and safety of the new Dextroamphetamine Transdermal System (d-ATS) to treat children and adolescents (aged 6–17 years) with attention-deficit/hyperactivity disorder (ADHD).
Ann Childress, Andrew Cutler
exaly   +2 more sources

Dextroamphetamine Saccharate [PDF]

Definitions, 2020
T he saccharate salt form of the dextro-isomer of amphetamine, a synthetic substance related to natural sympathomimetic amines, with CNS stimulating properties. Dextroamphetamine saccharate acts by facilitating the release of catecholamines, particularly
Dextroamphetamine Saccharate
openaire   +2 more sources

Real world pharmacovigilance comparison of viloxazine and dextroamphetamine adverse reaction profiles [PDF]

Scientific Reports
Viloxazine and dextroamphetamine as newly approved drugs for the medical treatment of Attention Deficit Hyperactivity Disorder (ADHD) in recent years give new options for the treating of related disorders, including anxiety, and depression.
Lijun Wang, Qingyang Kong, Yixuan Li
doaj   +2 more sources